4.3 Review

Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease

Journal

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
Volume 21, Issue 1, Pages 14-25

Publisher

BENTHAM SCIENCE PUBL
DOI: 10.2174/1871527320666210806165751

Keywords

Alzheimer's disease; gut microbiota; probiotics; faecal microbiota transplantation; beta-amyloid; central nervous system

Ask authors/readers for more resources

Alzheimer's disease is a neurodegenerative disease characterized by decline in memory and cognitive functions. Recent research suggests that gut microbiota plays a significant role in the disease and modulation of gut microbiota can be a potential therapeutic target. This review summarizes recent research findings and discusses current limitations and future research directions.
Alzheimer's disease is a neurodegenerative disease characterized by a progressive decline in memory and cognitive functions. It is a multifactorial disease involving a wide range of pathological factors that are not fully understood. As supported by a growing amount of evidence in recent years, gut microbiota plays an important role in the pathogenesis of Alzheimer's disease through the brain-gut-microbiota axis. This suggests that direct modulation of the gut microbiota can be a potential therapeutic target for Alzheimer's disease. This review summarizes recent research findings on the modulation of the gut microbiota by probiotic therapies and faecal microbiota transplantation for controlling the pathologies of Alzheimer's disease. Current limitations and future research directions of this field are also discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available